Background Change in life expectancy may be more readily appreciated by a lay person as a measure of risk than the standardized mortality ratio (SMR).
The results of epidemiological studies into the effect on mortality of factors such as occupation, geographical domicile or lifestyle, are commonly presented in terms of standardized mortality ratios (SMR). The SMR compares the mortality in a selected study population with that in a chosen standard population. It is calculated by applying the age-specific death rates in the standard population to the age structure of the study population to obtain the number of deaths that would have been expected if the study population had been subject to the same rates as those in die standard population. The SMR is then the ratio of the number of observed deaths in the study population to the number expected. If the SMR is greater than unity, the members of tile study group suffer a higher risk of dying; if less than unity, their mortality prospects are better.
These ratios may be difficult for the non-statistical lay person to interpret in a practical way as a measure of risk, and it has been suggested that changes in life expectancy may be a more easily understood and preferred measure of relative risk. 1 There have therefore been a few investigations into the relationship between the SMR and life expectancy. The Office of Population MRC Cancer Trials Office, 5 Shaftesbury Road, Cambridge CB2 2BW, UK.
Censuses and Surveys in its decennial supplement for England and Wales 1970-1972
2 plotted life expectancy at age 15 years against SMR for men in 25 different occupational categories. The life expectancies were calculated from life tables constructed using the observed age-specific mortality rates in the categories. An approximately linear inverse relationship was demonstrated over the range of SMR from 0.73 to 1.44. Tsai et al? derived a theoretical relationship between SMR and life expectancy which predicted that the logarithm of the ratio of the life expectancy, t e x , in the study population to o e^, that in the standard population, was linearly related in an Inverse manner to the SMR. Their equation was fitted to data for each of the 50 states of the US in order to estimate the slope of that relationship. In a later paper, 4 graphs of changes in life expectancy against changes in SMR were presented for males and females aged 25, 45 and 65 years respectively.
These approaches both relied on using a dataset consisting of values of SMR and the corresponding values of life expectancy to deduce a relationship between the two. Their applicability may be limited by the range of SMR covered by those datasets. An alternative method of tackling the problem is to make use of the Gompertz relationship between age-specific mortality rate and age. This paper describes the method and its application.
Method
Gompertz in 1825 showed that the mortality rate tended to increase exponentially with age. 5 This may be expressed mathematically by what is now commonly referred to as the Gompertz function: M* = Be .kx (1) where u^ is the mortality rate at age x and B and k are constants, the latter being the slope of the plot of In n^ against x. As will be demonstrated below, this function is still a reasonable representation of the pattern of mortality for people aged 30 and over in England and Wales. If it is assumed that the ratio of the age-specific mortality rate, l ii x , for the study population to oJix, that in the standard population, remains constant for all age groups, i.e. that k is the same for both populations, then:
Pollard 6 has provided a number of useful formulae derived from the Gompertz function, one of which is for the expectation of life, e x , at age x, namely:
Thus, by deducing jU^ from (2) for a given SMR and substituting in (3), the corresponding life expectancy can be found. If H-j/k is small compared with unity, as is the case at younger ages (see below), equation (3) for the standard population may be written:
o e x and similarly for the study population.
The change in life expectancy corresponding to a given SMR is then: Note that this expression for the change in life expectancy is independent of the absolute values of the ^ and depends only on their ratio, i.e. the SMR. It is also only valid if the ratio of the age-specific mortality rates remains constant over the age range being studied. Life expectancies for England and Wales in 1992 have been calculated using equation (3) and compared with those produced by the Office of National Statistics (ONS) for 1991-1993. 7 Equation (2) has been used to calculate the age-specific death rates that would result from different values of SMR if 1992 was taken as the standard. Substitution in equation (3) then predicted the corresponding life expectancies in the study population, and hence the change in life expectancy for a given SMR.
To check the validity of the Gompertz approach, the agespecific mortality rates for 1992 have been applied to the population figures for England and Wales in 1952
s to obtain values of SMR. The corresponding changes in life expectancy predicted by the Gompertz method have then been compared with the differences between the published life expectancies for 1951-1953 9 and those for 1991-1993. 7 Results Figure 1 shows a plot of the logarithm of the age-specific mortality rates against age in 5-year age groups for England and Wales in 1992. 10 It can be seen that from the 30-34 age group onwards the points lie very close to straight lines for both males and females. Table 1 gives the values of B and k for the lines fitted to the points from age group 30-34 upwards. Similar values derived from the mortality data for 1952 8 are also shown in Table 1 and will be referred to later. Table 2 lists the values of u^/k at ages 15, 25, 45 and 65 yean and demonstrates the small values of the ratio at younger ages. Table 3 compares the life expectancies calculated from equation (3) with those published by the ONS. 7 The differences are all «2% except for males aged 15 where the difference is 2.4%. (4) provides a very good estimate. At age 45 the approximate formula tends to overestimate slightly the changes in life expectancy. By the age of 65 it is not at all applicable. This is to be expected from the values of p^/k in Table 2 . The values for males and females aged 25, 45 and 65 are plotted against SMR in Figure 2 .
To test the usefulness of the curves in Figure 2 , the SMR for males and females for England and Wales in 1952 have been calculated using 1992 as standard. These have then been used to read off from Figure 2 the predicted changes in life expectancy. In Table 5 the prediaed values are compared with those that aaually occurred, i.e. those obtained from the published life tables. 7 ' Agreement is reasonably good, but the aaual values tend to be higher than those predicted, particularly at younger ages. So far it has been assumed that the age-specific mortality ratio is constant with age, i.e. k is the same for the populations being compared. Table 1 demonstrates that this is not so, the values of k being lower in 1952. To investigate this further, k for the study population was varied while the value of B for that population was adjusted so that the SMR remained constant. It was then found that life expectancies decreased as k decreased. For example, at ages 15 and 25 years the decrease in life expectancy for males, as k decreased from 0.11 to 0.08, was approximately 2 years if the SMR remained constant at 1.5. Thus, since the values of k were less in 1952 than in 1992, one would expect that the actual life expectancies would be a little lower than the predicted values, and therefore the changes In life expectancies would be a little higher than predicted. This would account for a part of the differences between actual and predicted change in Table 5 , about 0.2 years for males and 0.4 years for females.
As a further test of the validity of the Gompertz approach, and in a different context, the difference between life expectancies for male cigarette smokers and non-smokers has been examined. The log-linear relationship between age-specific mortality rates and age has already been shown in data from the early investigations into smoking and mortality.
11 Mortality rates in quinquennia from age 35 to 79 from a more recent study, the American Cancer Society's second Cancer Prevention Study (ACS CPSII), have been published in the appendix to Peto et al. 12 Log-linear plots of these data show that the Gompertz relationship holds good over this range except for non-smokers aged 35-39 where the mortality rate lies well above a linear projection. Regression lines fitted to the data from the 40-45 age group upwards result in values of k equal to 0.0918 and 0.1014 for smokers and non-smokers respectively. In the Surgeon General's Report of 1989, 13 the relative risk derived from the 1982-1986 data of the ACS CPSII study is quoted as 2.34. Although the period for the calculation of this relative risk is not quite the same as that for the mortality rates (1984) (1985) (1986) (1987) (1988) , the computation is similar to that for an SMR, and substituting in equation (4), together with the value of k for non-smokers, gives a difference in life expectancies of 8.4 years. This can be compared with the difference obtained when life expectancies at age 40 are estimated from the mortality rates by the method of Peto etal. 12 To use the method one needs to make some assumption about mortality rates above age 80. If one assumes that the Gompertz plots can be extrapolated beyond the 75-79 age group, equation (3) predicts that the life expectancies at age 80 for smokers and nonsmokers are 6.2 and 9.9 years respectively. Using these values and the method of Peto et al. the calculated life expectancies at age 40 are 34.7 and 43.4 years for smokers and non-smokers respectively, a difference of 8.7 years. Equation (4) has again predicted a slightly lower value, but this would be consistent with the value of k being lower for smokers than for nonsmokers.
Discussion
Pollard 6 showed that his formula for life expectancy, equation (3), provided comparable estimates to those in the published life tables for the Federal Republic of Germany in 1986 and in Yugoslavia in 1980. Table 3 confirms its applicability to the England and Wales mortality data for 1992. Changes of life expectancy with SMR can also be predicted (Table 4) , and at younger ages by the very simple formula of equation (4) .
The curves In Figure 2 have similar characteristics to those published by Lai et al. 4 in that the changes of life expectancy due to changes in SMR are greater at younger than at older ages. However, the changes predicted by Lai et al. tend to be more than those shown in Figure 2 , the discrepancy increasing as the SMR differs further from unity. Part of this discrepancy can be accounted for by their use of the mortality data for white US males and females in 1980 for whom the values of k are about 0.09 compared with the values of about 0.10 on which the curves in Figure 2 are based. Another possible explanation for the discrepancy is that although their curves are drawn for a range of SMRs from 0.4 to 2.0, the data from which their formulae are deduced cover a much smaller range, from about 0.8 to 1.1.
There are two main sources of possible error in the Gompertz approach. The first would, of course, occur if the Gompertz equation did not fit the mortality data. Even when it does, as demonstrated in Figure 1 , there is still uncertainty about its applicability at the older end of the age range. Although the mortality data for England and Wales in 1992 were available up to the 85-89 quinquennium, for 1952 they only went up to 80-84, and for the ACS CPSH study up to 75-79 years. A similar assumption about mortality at older ages has to be made when using the method of Peto et al. 12 to calculate life expectancies. The good agreement found above between the reduction in life expectancy of smokers compared with non-smokers predicted by the Gompertz method and that of Peto et al. is not therefore altogether surprising since both in effect make the same assumptions about mortality from age 80 upwards. The second source of error arises when the value of k for the study population differs from that of the standard population, i.e. the ratio of the age-specific mortality rates is not constant with age. In both the examples examined above, k was less for the study population. In such a situation the change in life expectancy is underestimated by the curves in Figure 2 .
Gain or loss of life expectancy is an estimate of risk that, for the lay person, may be more easily appreciated than the SMR. A way of relating the two measures could therefore be helpful in presenting the harm or benefit implied by a given SMR. The Gompertz method described above is relatively simple. The curves in Figure 2 may be used provided that the value of k for the standard population is close to that for England and Wales in 1992, i.e. -0.1. For younger age groups *45 a good approximation to the change is given by -(hi SMR)/k where k may be found from a plot of age-specific mortality rate against age for the standard population. Although the accuracy of the method may be limited for the reasons given above, it nevertheless could provide a quick way of judging the loss or gain in life expectancy that is associated with an SMR value.
